1.81
price down icon4.23%   -0.08
after-market 시간 외 거래: 1.86 0.05 +2.76%
loading
전일 마감가:
$1.89
열려 있는:
$1.87
하루 거래량:
358.06K
Relative Volume:
1.19
시가총액:
$119.24M
수익:
-
순이익/손실:
$-86.08M
주가수익비율:
-0.839
EPS:
-2.1574
순현금흐름:
$-72.06M
1주 성능:
-18.47%
1개월 성능:
+24.83%
6개월 성능:
+89.33%
1년 성능:
+25.69%
1일 변동 폭
Value
$1.80
$2.03
1주일 범위
Value
$1.80
$2.20
52주 변동 폭
Value
$0.66
$2.4773

Io Biotech Inc Stock (IOBT) Company Profile

Name
명칭
Io Biotech Inc
Name
전화
(457) 070-2980
Name
주소
OLE MAALOES VEH 3, COPENHAGEN
Name
직원
79
Name
트위터
Name
다음 수익 날짜
2025-08-08
Name
최신 SEC 제출 서류
Name
IOBT's Discussions on Twitter

IOBT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
IOBT
Io Biotech Inc
1.81 129.13M 0 -86.08M -72.06M -2.1574
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
366.54 98.88B 11.42B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.00 58.84B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
438.93 56.12B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
661.83 41.20B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
288.18 35.49B 3.81B -644.79M -669.77M -6.24

Io Biotech Inc 주식(IOBT)의 최신 뉴스

pulisher
01:26 AM

Major Phase 3 Results Coming: IO Biotech's Novel Melanoma Treatment Could Challenge Standard of Care - Stock Titan

01:26 AM
pulisher
Aug 10, 2025

IO Biotech Stock (IOBT) Opinions on Phase 3 Clinical Trial Risks - Quiver Quantitative

Aug 10, 2025
pulisher
Aug 10, 2025

Forecasting IO Biotech Inc. price range with options dataFree Step-by-Step Stock Investment Guide - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

IO Biotech to announce Phase 3 melanoma treatment results By Investing.com - Investing.com Canada

Aug 10, 2025
pulisher
Aug 10, 2025

IO Biotech to announce Phase 3 melanoma treatment results - Investing.com

Aug 10, 2025
pulisher
Aug 10, 2025

IO Biotech to Announce Pivotal Phase 3 Trial Results on August 11, 2025. - AInvest

Aug 10, 2025
pulisher
Aug 10, 2025

IO Biotech to Announce Topline Results of Pivotal Phase 3 Trial of Cylembio® in Combination with KEYTRUDA® (pembrolizumab) as a First-Line Treatment for Patients with Advanced Melanoma - The Manila Times

Aug 10, 2025
pulisher
Aug 10, 2025

Identifying reversal signals in IO Biotech Inc.Free Long Hold Safe Return Strategy - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

IO Biotech (IOBT) Projected to Post Earnings on Tuesday - Defense World

Aug 10, 2025
pulisher
Aug 10, 2025

Why IO Biotech Inc. is moving todayEntry Zone Forecast for Momentum Trading - Newser

Aug 10, 2025
pulisher
Aug 09, 2025

IO Biotech IOBT 2025Q2 Earnings Preview Downside Ahead on Revenue Challenges - AInvest

Aug 09, 2025
pulisher
Aug 09, 2025

T Inc. this weekYield Curve Outlook and Long-Term Implication Summary - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

Professional Diversity Network Inc. stock momentum explainedReversal Pattern Insights with Entry Tips - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

Live market analysis of IO Biotech Inc.Free Wealth Building Stock Market Ideas - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

What high frequency data says about IO Biotech Inc.Market Sentiment Tracker with Smart Alerts - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

Volatility clustering patterns for IO Biotech Inc.Free Trade Ready Stock Watch for Short Term - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

Using fundamentals and technicals on IO Biotech Inc.Free Low Risk Picks for Daily Trading - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

Is IO Biotech Inc. a candidate for recovery playSmart Trade Forecast Based on Neural Logic - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

Custom watchlist performance reports with IO Biotech Inc.Early Entry Ideas with Momentum Potential - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

Real time pattern detection on IO Biotech Inc. stockFree Risk Adjusted Technical Entry Plan - Newser

Aug 09, 2025
pulisher
Aug 08, 2025

Published on: 2025-08-08 18:40:49 - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Published on: 2025-08-09 03:08:59 - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Will IO Biotech Inc. benefit from macro trendsInvestment Timing Strategy with Market Filters - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Developing predictive dashboards with IO Biotech Inc. dataAI Short-Term Gain Forecast with Data - Newser

Aug 08, 2025
pulisher
Aug 07, 2025

Why IO Biotech Inc. stock attracts strong analyst attentionFree Alpha Driven Watchlist With Alerts - Newser

Aug 07, 2025
pulisher
Aug 07, 2025

Option-related insider selling at Toromont Industries (TIH) - The Globe and Mail

Aug 07, 2025
pulisher
Aug 07, 2025

What makes IO Biotech Inc. stock price move sharplyGrowth Watchlist for Long Term Positioning - Newser

Aug 07, 2025
pulisher
Aug 06, 2025

Exit strategy if you’re trapped in IO Biotech Inc.Free Intraday Trend Analysis for Fast Gains - Newser

Aug 06, 2025
pulisher
Aug 06, 2025

Is IO Biotech Inc. stock overhyped or has real potentialWeekly Signal Report with Trend Summary - Newser

Aug 06, 2025
pulisher
Aug 05, 2025

Regression analysis insights on IO Biotech Inc. performanceFree Growth Based Stock Signal Screener - Newser

Aug 05, 2025
pulisher
Aug 05, 2025

How IO Biotech Inc. stock performs during market volatilityStock Entry Point Planner with Volume Spike - Newser

Aug 05, 2025
pulisher
Aug 05, 2025

Is IO Biotech Inc. stock a good hedge against inflationReal-Time Setup Summary with ROI Focus - Newser

Aug 05, 2025
pulisher
Aug 05, 2025

MDA SPACE AWARDED CONTRACTS FOR ROYAL CANADIAN NAVY UNCREWED AIRCRAFT SYSTEMS TO ENHANCE MARITIME OPERATIONS - The Globe and Mail

Aug 05, 2025
pulisher
Aug 05, 2025

Is IO Biotech Inc. stock ready for a breakoutSmart Trade Mapping with Entry Details - Newser

Aug 05, 2025
pulisher
Aug 04, 2025

Bull of the Day: Meta Platforms (META) - The Globe and Mail

Aug 04, 2025
pulisher
Aug 04, 2025

Order Book Volume Tilts Bullish on IO Biotech Inc.Market Entry and Exit Point Tips From Traders - metal.it

Aug 04, 2025
pulisher
Aug 04, 2025

Published on: 2025-08-04 00:17:08 - Newser

Aug 04, 2025
pulisher
Aug 04, 2025

Smart tools for monitoring IO Biotech Inc.’s price actionPredictive Model for Intraday Swing Forecast - Newser

Aug 04, 2025
pulisher
Aug 03, 2025

Should I hold or sell IO Biotech Inc. stock in 2025Explosive earning power - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What analysts say about IO Biotech Inc. stockFree Stock Market Trend Analysis - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is it the right time to buy IO Biotech Inc. stockTriple returns potential - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the risk reward ratio of investing in IO Biotech Inc. stockTriple-digit wealth increases - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is IO Biotech Inc. a good long term investmentBuild capital through low-risk investments - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is CIM.PRD a good long term investmentMassive stock growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What catalysts could drive IO Biotech Inc. stock higher in 2025Achieve rapid capital gains with smart investing - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How many analysts rate IO Biotech Inc. as a “Buy”Get daily updates on promising stocks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How volatile is IO Biotech Inc. stock compared to the marketGet daily expert analysis for smarter investing - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How strong is IO Biotech Inc. company’s balance sheetIdentify undervalued stocks ready to soar - Jammu Links News

Aug 03, 2025

Io Biotech Inc (IOBT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$78.39
price up icon 0.24%
$37.58
price up icon 1.54%
$109.55
price up icon 0.23%
$28.66
price up icon 2.10%
$111.66
price up icon 0.28%
biotechnology ONC
$288.18
price down icon 3.39%
자본화:     |  볼륨(24시간):